No Data
Huafu Securities: BASF delays the resumption time of vitamins E and A production, prices are expected to continue to rise.
Due to the explosion, BASF delayed the reproduction time of vitamins E and A. After this news was announced, vitamins E and A quickly stopped falling and rebounded.
Zhejiang Garden Biopharmaceutical (300401.SZ): Vitamins B6 and biotin projects are actively progressing as planned.
On October 21, zhejiang garden biopharmaceutical (300401.SZ) stated on the investor interaction platform that the company's VA project now has production capacity, and vitamins B6 and biotin projects are actively progressing according to plan.
Zhejiang Garden Biopharmaceutical (300401.SZ): The production and sales of vitamin D3 in the third quarter increased both year-on-year and quarter-on-quarter.
Zhejiang Garden Biopharmaceutical (300401.SZ) stated on the investor interaction platform on October 21 that the company's production and sales of vitamin D3 in the third quarter have increased year-on-year and quarter-on-quarter.
Garden Biology: Report for the third quarter of 2024
Gelonghui announcement selection | Yunnan Energy New Material: Shanghai Yunnan Energy plans to invest approximately 2 billion yuan in Malaysia to construct a lithium battery separator film project; Baoding Tianwei Baobian Electric: Currently, there are no
【Hotspot Tracking】Tianjin Troila Information Technology (600225.SH): There is no cybersecurity or Huawei folding screen-related revenue. Baoding Tianwei Baobian Electric (600550.SH): Currently not involved in the injection of company assets, business restructuring, or major business cooperation. Shanghai Highly (600619.SH): Hai Li Te Leng sells cooling systems for lithography machines, with a relatively small business scale. Eastern Communications (600776.SH): There are no major undisclosed issues that should be disclosed. 【Signed Projects】Yunnan Energy New Material (002812.SZ): Shanghai Yunnan Energy plans to invest around 2 billion yuan in Malaysia to build a lithium battery separator film project.
Garden Biology: Earnings Forecast for the First Three Quarters of 2024
Zhejiang Garden Biopharmaceutical Co.,Ltd.'s (SZSE:300401) Shares May Have Run Too Fast Too SoonNo Data
No Data
